返回 Agenda
Session 7: MERC Pharmacovigilance Session
Session Chair(s)
Reem K Al Essa, MBA
Coordination & Development Superintendent Pharmaceutical Services Administration
Ministry of Health, Kuwait
Hadir Rostom
Head, Egyptian Pharmaceutical Vigilance Center (EPVC)
Pharmaceutical Affairs Central Administration (CAPA), Ministry of Health, Egypt, Egypt
Session 7: MERC Pharmacovigilance Session
Speaker(s)
Sean Burke, MSc
Merck , United Kingdom
(EFPIA IPVG Representative) Pharmacovigilance Lead, EEMEA
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
The “Project 3-S”: Smart Safety Surveillance for priority medical products
Shanthi Pal, DrSc, MPharm
WHO, Switzerland
Group Lead, Medicines Safety, Safety & Vigilance
The SFDA Experience – Moving to the Investigation Phase
Mohammed Ebrahim Fouda, PharmD, RPh
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Head of Signal Detection Department
Kuwait’s Roadmap on Pharmacovigilance
Reem K Al Essa, MBA
Ministry of Health, Kuwait
Coordination & Development Superintendent Pharmaceutical Services Administration